| FAM84B promotes breast cancer tumorigenesis through activation of the NF-kappaB and death receptor signaling pathways. | FAM84B promotes breast cancer tumorigenesis through activation of the NF-κB and death receptor signaling pathways.
Zhang Y, Yang F. | 09/28/2023 |
| FAM84B promotes the proliferation of glioma cells through the cell cycle pathways. | FAM84B promotes the proliferation of glioma cells through the cell cycle pathways.
Ren D, Zhuang X, Lv Y, Zhang Y, Xu J, Gao F, Chen D, Wang Y., Free PMC Article | 12/3/2022 |
| FAM84B acts as a tumor promoter in human glioma via affecting the Akt/GSK-3beta/beta-catenin pathway. | FAM84B acts as a tumor promoter in human glioma via affecting the Akt/GSK-3β/β-catenin pathway.
Wang M, Li C, Shi W. | 01/8/2022 |
| Identification of Hub Genes in Gastric Cancer with High Heterogeneity Based on Weighted Gene Co-Expression Network. | Identification of Hub Genes in Gastric Cancer with High Heterogeneity Based on Weighted Gene Co-Expression Network.
Dong Z, Pei S, Zhao Y, Guo S, Wang Y. | 07/10/2021 |
| FAM84B, amplified in pancreatic ductal adenocarcinoma, promotes tumorigenesis through the Wnt/beta-catenin pathway. | FAM84B, amplified in pancreatic ductal adenocarcinoma, promotes tumorigenesis through the Wnt/β-catenin pathway.
Zhang X, Xu J, Yan R, Zhang Y, Hu Z, Fu H, You Q, Cai Q, Yang D., Free PMC Article | 02/27/2021 |
| The Oncogenic Potential of the Centromeric Border Protein FAM84B of the 8q24.21 Gene Desert. | The Oncogenic Potential of the Centromeric Border Protein FAM84B of the 8q24.21 Gene Desert.
Gu Y, Lin X, Kapoor A, Chow MJ, Jiang Y, Zhao K, Tang D., Free PMC Article | 02/2/2021 |
| non-coding RNA (lncRNA) FAM84B-AS promotes resistance of Gastric Cancer to platinum drugs through inhibition of FAM84B expression. | Long non-coding RNA FAM84B-AS promotes resistance of gastric cancer to platinum drugs through inhibition of FAM84B expression.
Zhang Y, Li Q, Yu S, Zhu C, Zhang Z, Cao H, Xu J. | 11/9/2019 |
| High FAM84B expression is associated with prostate cancer progression. | Upregulation of FAM84B during prostate cancer progression.
Wong N, Gu Y, Kapoor A, Lin X, Ojo D, Wei F, Yan J, de Melo J, Major P, Wood G, Aziz T, Cutz JC, Bonert M, Patterson AJ, Tang D., Free PMC Article | 10/7/2017 |
| Data suggest that FAM84B protein and the NOTCH pathway are involved in the progression of esophageal squamous cell carcinoma (ESCC) and may be potential diagnostic targets for ESCC susceptibility. | Genomic analyses reveal FAM84B and the NOTCH pathway are associated with the progression of esophageal squamous cell carcinoma.
Cheng C, Cui H, Zhang L, Jia Z, Song B, Wang F, Li Y, Liu J, Kong P, Shi R, Bi Y, Yang B, Wang J, Zhao Z, Zhang Y, Hu X, Yang J, He C, Zhao Z, Wang J, Xi Y, Xu E, Li G, Guo S, Chen Y, Yang X, Chen X, Liang J, Guo J, Cheng X, Wang C, Zhan Q, Cui Y., Free PMC Article | 10/22/2016 |
| We demonstrated the decreased of circulating FAM84B mRNA and protein after neoadjuvant CRT may predict pCR, and FAM84B protein is overexpressed in ESCC. | Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker In Predicting Pathological Response to Neoadjuvant Chemoradiation.
Hsu FM, Cheng JC, Chang YL, Lee JM, Koong AC, Chuang EY., Free PMC Article | 03/5/2016 |
| Observational study of gene-disease association. (HuGE Navigator) | See all PubMed (2) articlesVariation at 8q24 and 9p24 and risk of epithelial ovarian cancer.
White KL, Sellers TA, Fridley BL, Vierkant RA, Phelan CM, Tsai YY, Kalli KR, Berchuck A, Iversen ES, Hartmann LC, Liebow M, Armasu S, Fredericksen Z, Larson MC, Duggan D, Couch FJ, Schildkraut JM, Cunningham JM, Goode EL. Evaluation of the 8q24 prostate cancer risk locus and MYC expression.
Pomerantz MM, Beckwith CA, Regan MM, Wyman SK, Petrovics G, Chen Y, Hawksworth DJ, Schumacher FR, Mucci L, Penney KL, Stampfer MJ, Chan JA, Ardlie KG, Fritz BR, Parkin RK, Lin DW, Dyke M, Herman P, Lee S, Oh WK, Kantoff PW, Tewari M, McLeod DG, Srivastava S, Freedman ML. | 08/12/2009 |